American Portfolios Advisors - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 52 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$165
-19.9%
1500.0%0.00%
Q2 2020$206
+20.5%
1500.0%0.00%
Q1 2020$171
-50.0%
1500.0%0.00%
Q4 2019$342
+169.3%
1500.0%0.00%
Q3 2019$127
-13.0%
1500.0%0.00%
Q2 2019$146
-22.8%
1500.0%0.00%
Q1 2019$189
-61.1%
1500.0%0.00%
Q4 2018$486
+34.3%
1500.0%0.00%
Q3 2018$362
-13.6%
1500.0%0.00%
Q2 2018$419
-41.2%
1500.0%0.00%
Q1 2018$7131500.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders